Table 1.
Patient Characteristicsa
| Characteristic | I, N | I Mean/SD or % | C, N | C Mean/SD or % | Total, N | Total Mean/SD or % |
|---|---|---|---|---|---|---|
| Age | 61 | 69.5/7.7 | 101 | 65.7/8.5 | 162 | 67.1/8.4 |
| Grade | 61 | 2.2/0.7 | 101 | 2.1/0.7 | 162 | 2.1/0.7 |
| 1 | 6 | 9.8% | 19 | 18.8% | 25 | 15.4% |
| 2 | 35 | 57.4% | 53 | 52.5% | 88 | 54.3% |
| 3 | 20 | 32.8% | 29 | 28.7% | 49 | 30.2% |
| Sex | ||||||
| Male | 39 | 63.9% | 39 | 38.6% | 78 | 48.1% |
| Female | 22 | 36.1% | 62 | 61.4% | 84 | 51.8% |
| Histologic Subtype | ||||||
| Adenocarcinoma | 30 | 49.2% | 63 | 62.4% | 93 | 57.4% |
| Adenosquamous | 2 | 3.3% | 2 | 2.0% | 4 | 2.5% |
| Large cell | 2 | 3.3% | 11 | 10.9% | 13 | 8.0% |
| Squamous | 26 | 42.6% | 22 | 21.8% | 48 | 29.6% |
| Unknown | 1 | 1.6% | 3 | 3.0% | 4 | 2.5% |
| Smoking Status | ||||||
| Nonsmoker | 12 | 19.7% | 19 | 18.8% | 31 | 19.1% |
| Smoker | 47 | 77.0% | 74 | 73.3% | 121 | 74.7% |
| Unknown | 2 | 3.3% | 8 | 7.9% | 10 | 6.2% |
| Recurrence | ||||||
| Yes | 20 | 32.8% | 6 | 5.9% | 26 | 16.0% |
| No | 39 | 63.9% | 93 | 92.0% | 132 | 81.5% |
| Unknown | 2 | 3.3% | 2 | 2.0% | 4 | 2.5% |
| Tumor Position | ||||||
| Lower lobe | 18 | 29.5% | 26 | 25.7% | 44 | 27.1% |
| Middle lobe | 5 | 8.2% | 5 | 4.9% | 10 | 6.1% |
| Upper lobe | 36 | 59.0% | 63 | 62.4% | 99 | 61.1% |
| Upper/lower lobes | 0 | 0.00% | 2 | 2.0% | 2 | 1.2% |
| Upper/middle lobes | 0 | 0.00% | 1 | 1.0% | 1 | 0.6% |
| Chest wall | 0 | 0.00% | 1 | 1.0% | 1 | 0.6% |
| Main stem bronchus | 0 | 0.00% | 1 | 1.0% | 1 | 0.6% |
| Unknown | 2 | 3.3% | 2 | 2.0% | 4 | 2.5% |
| Treatment | ||||||
| Yes | 10 | 16.4% | 9 | 8.9% | 19 | 11.7% |
| No | 51 | 83.6% | 92 | 91.0% | 143 | 88.3% |
| Stage I | ||||||
| A | 37 | 60.6% | 73 | 72.3% | 110 | 67.9% |
| B | 24 | 39.3% | 28 | 27.7% | 52 | 32.1% |
| KP | 61 | 96.9/6.6 | 101 | 97.1/3.9 | 162 | 97.0/5.1 |
| KS | 61 | 289.4/24.8 | 101 | 288.3/21.5 | 162 | 288.7/22.8 |
| PI | 61 | 2.5/0.6 | 101 | 2.5/0.6 | 162 | 2.5/0.6 |
| PP | 61 | 83.5/17.5 | 101 | 84.9/18.2 | 162 | 84.4/17.9 |
| PS | 61 | 223.4/76.2 | 101 | 221.5/77.4 | 162 | 222.3/76.7 |
a
This table provides the patient characteristics for the incident group (I), censored group (C), and totals. The number of samples (N), mean values, standard deviation (SD), and percentages (%) are provided for each characteristic where applicable. The C and I groups correspond to the favorable and unfavorable outcome groups, respectively. The DNA expression measures for KU86 and PARP for the intensity, proportions and total score are A, KI, KP, KS and PI, PP, and PS, respectively.